Organ-organ communication: The liver's perspective
- PMID: 33537089
- PMCID: PMC7847667
- DOI: 10.7150/thno.55795
Organ-organ communication: The liver's perspective
Abstract
Communication between organs participates in most physiological and pathological events. Owing to the importance of precise coordination among the liver and virtually all organs in the body for the maintenance of homeostasis, many hepatic disorders originate from impaired organ-organ communication, resulting in concomitant pathological phenotypes of distant organs. Hepatokines are proteins that are predominantly secreted from the liver, and many hepatokines and several signaling proteins have been linked to diseases of other organs, such as the heart, muscle, bone, and eyes. Although liver-centered interorgan communication has been proposed in both basic and clinical studies, to date, the regulatory mechanisms of hepatokine production, secretion, and reciprocation with signaling factors from other organs are obscure. Whether other hormones and cytokines are involved in such communication also warrants investigation. Herein, we summarize the current knowledge of organ-organ communication phenotypes in a variety of diseases and the possible involvement of hepatokines and/or other important signaling factors. This provides novel insight into the underlying roles and mechanisms of liver-originated signal transduction and, more importantly, the understanding of disease in an integrative view.
Keywords: Cytokine; Disease mechanism.; Hepatokine; Liver; Organ communication.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures


Similar articles
-
Liver-based inter-organ communication: A disease perspective.Life Sci. 2024 Aug 15;351:122824. doi: 10.1016/j.lfs.2024.122824. Epub 2024 Jun 9. Life Sci. 2024. PMID: 38862061 Review.
-
Hepatokines and metabolism: Deciphering communication from the liver.Mol Metab. 2021 Feb;44:101138. doi: 10.1016/j.molmet.2020.101138. Epub 2020 Dec 4. Mol Metab. 2021. PMID: 33285302 Free PMC article. Review.
-
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.Biomedicines. 2021 Dec 14;9(12):1903. doi: 10.3390/biomedicines9121903. Biomedicines. 2021. PMID: 34944728 Free PMC article. Review.
-
Newly discovered endocrine functions of the liver.World J Hepatol. 2021 Nov 27;13(11):1611-1628. doi: 10.4254/wjh.v13.i11.1611. World J Hepatol. 2021. PMID: 34904032 Free PMC article. Review.
-
LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance.Diabetes. 2014 May;63(5):1649-64. doi: 10.2337/db13-0728. Epub 2014 Jan 29. Diabetes. 2014. PMID: 24478397
Cited by
-
Insights into the liver-eyes connections, from epidemiological, mechanical studies to clinical translation.J Transl Med. 2023 Oct 10;21(1):712. doi: 10.1186/s12967-023-04543-3. J Transl Med. 2023. PMID: 37817192 Free PMC article. Review.
-
Metabolic Dysfunction-Associated Steatotic Liver Disease Induced by Microplastics: An Endpoint in the Liver-Eye Axis.Int J Mol Sci. 2025 Mar 21;26(7):2837. doi: 10.3390/ijms26072837. Int J Mol Sci. 2025. PMID: 40243419 Free PMC article. Review.
-
The Critical Role of Lipid Metabolism in Health and Diseases.Nutrients. 2024 Dec 23;16(24):4414. doi: 10.3390/nu16244414. Nutrients. 2024. PMID: 39771035 Free PMC article.
-
Role of the serum levels of the inter-organs messenger fibroblast growth factor 21 (FGF21) in the diagnosis and prognosis of breast cancer patients.Cell Commun Signal. 2025 Jan 21;23(1):37. doi: 10.1186/s12964-024-02003-z. Cell Commun Signal. 2025. PMID: 39838482 Free PMC article.
-
Crosstalk between adipose tissue and the microbiota-gut-brain axis in metabolic diseases.Int J Biol Sci. 2022 Feb 7;18(4):1706-1723. doi: 10.7150/ijbs.68786. eCollection 2022. Int J Biol Sci. 2022. PMID: 35280695 Free PMC article. Review.
References
-
- Xiao J, Wang F, Wong NK, He J, Zhang R, Sun R. et al. Global liver disease burdens and research trends: Analysis from a Chinese perspective. J Hepatol. 2019;71:212–21. - PubMed
-
- Rahimi RS, Rockey DC. End-stage liver disease complications. Curr Opin Gastroenterol. 2013;29:257–63. - PubMed
-
- Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014;59:1174–97. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources